Počet záznamov: 1  

CYP and GST polymorphisms and survival in advanced non-small cell lung cancer patients

  1. SYS0054178
    LBL
      
    00000naa^^22^^^^^^^^450
    005
      
    20130416123250.5
    100
      
    $a 20101104a2010 m y0sloy0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a CYP and GST polymorphisms and survival in advanced non-small cell lung cancer patients $f A. O. Ada ... [et al.]
    215
      
    $c ilustr., obr., tab.
    320
      
    $a Bibliogr. odkazy
    320
      
    $a Res. angl.
    463
    -1
    $1 001 sllk_un_cat*0053464 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 57, no. 6 (2010), s. 512-521 $1 210 $a Bratislava $c AEPress $d 2010 $1 215 $a s. 495-601
    541
    1-
    $a CYP a GST polymorfizmy a prežívanie pacientov pri pokročilej nemalobunkovej pľúcnej rakovine $z slo
    606
    1-
    $3 sllk_un_auth*d008175 $a nádory pľúc $x diagnostika $x patológia $2 mesh
    606
    1-
    $3 sllk_un_auth*d002289 $a karcinóm pľúc, nemalobunkový $x diagnostika $x genetika $2 mesh
    606
    1-
    $3 sllk_un_auth*d011110 $a polymorfizmus genetický $2 mesh
    606
    2-
    $3 sllk_un_auth*d019363 $a cytochróm P-450 CYP1A1 $2 mesh
    606
    2-
    $3 sllk_un_auth*d005982 $a glutatióntransferáza $2 mesh
    606
    2-
    $3 sllk_un_auth*d005838 $a genotyp $2 mesh
    606
    2-
    $3 sllk_un_auth*d012907 $a fajčenie $2 mesh
    606
    2-
    $3 sllk_un_auth*d013534 $a prežívanie $2 mesh
    606
    2-
    $3 sllk_un_auth*d011379 $a prognóza $2 mesh
    610
    2-
    $a polymorfizmus CYP1A1 a CYP1B1
    610
    2-
    $a analýza multivariačná
    610
    2-
    $a chemoterapia
    610
    2-
    $a prežívanie celkové
    701
    -1
    $3 sllk_un_auth*0017564 $a Ada $b A. O. $4 070 $p Department of Toxicology, Faculty of Pharmacy, Ankara University, Ankara, Turkey
    701
    -1
    $3 sllk_un_auth*0017565 $a Kunak $b S. C. $4 070 $p Department of Pharmacology, Medical Faculty, Giresun University, Giresun, Turkey
    701
    -1
    $3 sllk_un_auth*0017566 $a Hancer $b F. $4 070 $p Department of Toxicology, Faculty of Pharmacy, Ankara University, Ankara, Turkey
    701
    -1
    $3 sllk_un_auth*0017567 $a Bilgen $b S. $4 070 $p Department of Toxicology, Faculty of Pharmacy, Ankara University, Ankara, Turkey
    701
    -1
    $3 sllk_un_auth*0017568 $a Huzen $b S. H. $4 070 $p Department of Toxicology, Faculty of Pharmacy, Ankara University, Ankara, Turkey
    701
    -1
    $3 sllk_un_auth*0017569 $a Alpar $b S. $4 070 $p Pulmonary Diseases Clinic, Ataturk Pulmonary Diseases and Thoracic Surgery Hospital, Ankara, Turkey
    701
    -1
    $3 sllk_un_auth*0017571 $a Gulhan $b M. $4 070 $p Department of Chest Diseases, Ridvan Ege Hospital, Ufuk University, Ankara, Turkey
    701
    -1
    $3 sllk_un_auth*0017573 $a Kurt $b B. $4 070 $p Department of Chest Diseases, Izzet Baysal Medical Faculty, Abant Izzet Baysal University, Bolu, Turkey
    701
    -1
    $3 sllk_un_auth*p0045934 $a Iscan $b M. $4 070 $p Department of Biological Sciences, Faculty of Arts and Sciences, Middle East Technical University, 06531, Ankara, Turkey
    801
    -0
    $a SK $b BA006 $c 20101104 $g AACR2
Počet záznamov: 1  

  Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom ako používame cookies.